Document is current
Any future updates will be listed below
-
Authors
Carr, Sinclair https://orcid.org/0000-0003-0421-3145
Bryazka, Dana
McLaughlin, Susan A.
Zheng, Peng
Bahadursingh, Sarasvati
Aravkin, Aleksandr Y.
Hay, Simon I. https://orcid.org/0000-0002-0611-7272
Lawlor, Hilary R.
Mullany, Erin C.
Murray, Christopher J. L. https://orcid.org/0000-0002-4930-9450
Nicholson, Sneha I.
Rehm, Jürgen
Roth, Gregory A.
Sorensen, Reed J. D.
Lewington, Sarah
Gakidou, Emmanuela https://orcid.org/0000-0002-8992-591X
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 8 April 2024
First Online: 14 May 2024
Competing interests
: G.A.R. has received support for this manuscript from the Bill and Melinda Gates Foundation [OPP1152504]. S.L. has received grants or contracts from the UK Medical Research Council [MR/T017708/1], CDC Foundation [project number 996], World Health Organization [APW No 2021/1194512], and is affiliated with the NIHR Oxford Biomedical Research Centre. The University of Oxford’s Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) is supported by core grants from the Medical Research Council [Clinical Trial Service Unit A310] and the British Heart Foundation [CH/1996001/9454]. The CTSU receives research grants from industry that are governed by University of Oxford contracts that protect its independence and has a staff policy of not taking personal payments from industry. All other authors declare no competing interests.
